Alpha IVF Group Berhad Valuation

Q: What is the Fair Price of ALPHA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ALPHA (MYR0.37) is trading above our estimate of [[fair value]] (MYR0.14)

Is ALPHA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALPHA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ALPHA (MYR0.37) is trading above our estimate of fair value (MYR0.14)

Significantly Below Fair Value: ALPHA is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALPHA?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for ALPHA. This is calculated by dividing ALPHA's market cap by their current preferred multiple.
What is ALPHA's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	RM 1.77b

ALPHA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	9.8x
Enterprise Value/EBITDA	22.4x
PEG Ratio	1.9x

Price to Earnings Ratio vs Peers

How does ALPHA's PE Ratio compare to its peers?

The above table shows the PE ratio for ALPHA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	35.2x
TMCLIFE TMC Life Sciences Berhad	23.8x	n/a	RM 966.7m
MHCARE Metro Healthcare Berhad	77.5x	n/a	RM 388.5m
OPTIMAX Optimax Holdings Berhad	28.4x	16.9%	RM 364.0m
FOCUSP Focus Point Holdings Berhad	11.1x	10.6%	RM 362.7m
ALPHA Alpha IVF Group Berhad	33.5x	17.4%	RM 1.8b

Price-To-Earnings vs Peers: ALPHA is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the peer average (21.1x).

Price to Earnings Ratio vs Industry

How does ALPHA's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	2.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	2.4%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: ALPHA is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the Asian Healthcare industry average (24.2x).

Price to Earnings Ratio vs Fair Ratio

What is ALPHA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALPHA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	33.5x
Fair PE Ratio	26.5x

Price-To-Earnings vs Fair Ratio: ALPHA is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the estimated Fair Price-To-Earnings Ratio (26.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALPHA forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	RM 0.36	RM 0.40 +9.6%	4.1%	RM 0.42	RM 0.38	n/a	3
Sep ’25	RM 0.32	RM 0.40 +25.0%	4.1%	RM 0.42	RM 0.38	n/a	3
Aug ’25	RM 0.33	RM 0.40 +23.1%	4.1%	RM 0.42	RM 0.38	n/a	3
Jul ’25	RM 0.31	RM 0.40 +29.0%	4.1%	RM 0.42	RM 0.38	n/a	3
Jun ’25	RM 0.32	RM 0.40 +27.0%	4.1%	RM 0.42	RM 0.38	n/a	3
May ’25	RM 0.33	RM 0.40 +23.1%	4.1%	RM 0.42	RM 0.38	n/a	3

Analyst Forecast: Target price is less than 20% higher than the current share price.